BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2764523)

  • 1. Synthesis and biological evaluation of new Rh (I) complexes with sulfonamide derivatives.
    Craciunescu G; Scarcia V; Furlani A; Iglesias EP; Ghirvu C; Papaioannou A
    Anticancer Res; 1989; 9(3):781-5. PubMed ID: 2764523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan.
    Di Luzio NR; Williams DL; McNamee RB; Edwards BF; Kitahama A
    Int J Cancer; 1979 Dec; 24(6):773-9. PubMed ID: 397198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma with renal dense deposits containing tumor antigens.
    Olson JL; Philips TM; Lewis MG; Solez K
    Clin Nephrol; 1979 Aug; 12(2):74-82. PubMed ID: 393445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-dichlorodiammineplatinum(II) alone and combined with DTIC for treatment of disseminated malignant melanoma.
    Goodnight JE; Moseley HS; Eilber FR; Sarna G; Morton DL
    Cancer Treat Rep; 1979; 63(11-12):2005-7. PubMed ID: 393385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) with or without Corynebacterium parvum in metastatic malignant melanoma.
    Presant CA; Bartolucci AA; Smalley RV; Vogler WR
    Cancer; 1979 Sep; 44(3):899-905. PubMed ID: 383276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DTIC in malignant melanoma: a perspective (author's transl)].
    Kokoschka EM
    Wien Klin Wochenschr; 1978 Dec; 90(24):870-4. PubMed ID: 369152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is SP1 (pregnancy specific beta 1 glycoprotein) elevated in cancer patients?
    Engvall E; Yonemoto RH
    Int J Cancer; 1979 Dec; 24(6):759-61. PubMed ID: 317495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumours.
    Byrom NA; Retsas S; Dean AJ; Hobbs JR
    Clin Oncol; 1978 Mar; 4(1):25-34. PubMed ID: 305835
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth of human melanoma in nude mice: suppression by T-lymphocytes from the tumor donor: brief communication.
    Coates AS; Crawford M
    J Natl Cancer Inst; 1977 Oct; 59(4):1325-9. PubMed ID: 302865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryosurgical and thermal monitoring system for management of malignancy.
    Najjar TA; Wilchins S; Levy M; Hrycak P
    Oral Surg Oral Med Oral Pathol; 1979 Feb; 47(2):114-9. PubMed ID: 284272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for malignant melanoma: a brief review and personal experience.
    Milton GW; McCarthy WH
    Aust N Z J Surg; 1978 Feb; 48(1):53-5. PubMed ID: 96784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor activity and preclinical pharmacologic evaluation of pingyangmycin (author's transl)].
    Lin FT; Li DD; Yang XP; Li Q; Xue YC; Zhen YS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):161-6. PubMed ID: 95444
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytostatic treatment of meningeal blastoses.
    Engelhardt P; Lorenz R
    J Neurol; 1979 Jan; 220(4):279-89. PubMed ID: 90137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated antigens of chemically-induced murine tumors; the emergence of MuLV and fetal antigens after serial passage in culture.
    Cleveland PH; Belnap LP; Knotts FB; Nayak SK; Baird SM; Pilch YH
    Int J Cancer; 1979 Mar; 23(3):380-91. PubMed ID: 86520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine and human melanomas containing a high molecular weight RNA associated with an RNA-instructed DNA polymerase.
    Hehlmann R; Balda BR; Spiegelman S
    Int J Dermatol; 1978 Mar; 17(2):115-22. PubMed ID: 77259
    [No Abstract]   [Full Text] [Related]  

  • 16. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
    Grosser N; Thompson DM
    Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHrmonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic AMP on the tyrosinase activity of mouse melanoma cells, in vitro.
    Lee TH; Lee MS
    Biochim Biophys Acta; 1976 Aug; 444(1):181-91. PubMed ID: 8131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Free radicals as possible melanogenesis regulators].
    Bogdanov GN; Goloshchapov AN; Shtol'ko VN
    Izv Akad Nauk SSSR Biol; 1978; (1):143-7. PubMed ID: 415083
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear nonhistone proteins in murine melanoma cells: II. changes following exposure to MSH.
    Wikswo MA; McGuire J; Shansky JE; Boshes RA
    J Invest Dermatol; 1977 Dec; 69(6):516-20. PubMed ID: 411835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histochemical and ultrastructural investigations on invasive growth of tumour. I. Enzyme-histochemical investigations (author's transl)].
    Hecker VD
    Acta Histochem; 1977; 58(1):105-24. PubMed ID: 404821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.